Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||
net income | 29,631,000 | -12,007,000 | -4,160,000 | -15,899,000 | 38,896,000 | -13,880,000 | -6,217,000 | 1,287,000 | 10,643,000 | -16,813,000 | -3,683,000 | -1,129,000 | -4,272,000 | -23,797,000 | -10,149,000 | -11,281,000 | 9,994,000 |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||
unrealized gain on foreign exchange rates | |||||||||||||||||
depreciation and amortization | 6,767,000 | 6,768,000 | 5,502,000 | 4,654,000 | 4,246,000 | 4,204,000 | 4,259,000 | 3,990,000 | 3,898,000 | 4,145,000 | 3,731,000 | 3,118,000 | 3,402,000 | 2,967,000 | 2,817,000 | 2,427,000 | 2,266,000 |
stock-based compensation expense | 17,733,000 | 17,522,000 | 18,218,000 | 16,537,000 | 16,493,000 | 17,061,000 | 14,842,000 | 12,427,000 | 11,320,000 | 11,376,000 | 8,603,000 | 7,798,000 | 8,529,000 | 8,437,000 | 5,495,000 | 3,390,000 | 2,778,000 |
amortization of deferred contract costs | 399,000 | 392,000 | 376,000 | 146,000 | 309,000 | 275,000 | 242,000 | 139,000 | 119,000 | 109,000 | 1,556,000 | 82,000 | 89,000 | 72,000 | 66,000 | 74,000 | |
change in fair value of contingent consideration | -721,000 | -667,000 | 165,000 | 10,000 | -94,000 | -416,000 | -478,000 | 0 | -30,000 | 0 | 410,000 | -3,102,000 | 1,247,000 | -880,000 | -70,000 | 191,000 | 481,000 |
deferred tax benefit | -2,194,000 | -5,555,000 | -402,000 | -643,000 | -312,000 | 36,000 | -620,000 | ||||||||||
change in benefit from uncollectible accounts | 1,377,000 | ||||||||||||||||
amortization of debt issuance costs | 81,000 | ||||||||||||||||
net accretion of discounts and amortization of premiums on investments | -17,000 | ||||||||||||||||
changes in operating assets and liabilities, net of acquisitions: | |||||||||||||||||
accounts receivable | -11,754,000 | 3,661,000 | -3,492,000 | 3,766,000 | -7,119,000 | -482,000 | -1,457,000 | 2,897,000 | 1,207,000 | -1,862,000 | -4,324,000 | 3,993,000 | -607,000 | -2,870,000 | -839,000 | 879,000 | -1,338,000 |
unbilled receivables | 4,338,000 | -6,301,000 | 4,068,000 | -3,794,000 | 1,393,000 | -5,057,000 | 2,694,000 | -3,883,000 | 0 | -2,758,000 | 1,247,000 | 377,000 | -1,685,000 | -1,749,000 | 1,129,000 | -1,580,000 | -754,000 |
funds receivable from payment partners | -44,560,000 | -23,999,000 | 25,873,000 | 40,281,000 | -45,417,000 | -8,743,000 | 37,714,000 | -33,446,000 | -37,178,000 | -14,674,000 | 34,323,000 | -28,827,000 | -10,194,000 | -1,029,000 | 9,133,000 | -6,390,000 | -4,871,000 |
prepaid expenses, other current assets and other assets | -3,436,000 | -8,717,000 | -9,151,000 | 1,862,000 | -2,763,000 | -6,284,000 | 1,863,000 | 257,000 | -3,506,000 | -202,000 | -828,000 | -3,644,000 | -3,997,000 | ||||
funds payable to clients | 147,102,000 | 47,416,000 | -111,175,000 | -80,451,000 | 182,048,000 | -7,920,000 | -86,810,000 | 78,453,000 | 50,510,000 | 17,996,000 | -60,343,000 | 52,730,000 | 5,190,000 | 7,386,000 | -16,374,000 | 4,447,000 | 21,344,000 |
accounts payable, accrued expenses and other current liabilities | 10,194,000 | 2,473,000 | -5,130,000 | -5,143,000 | 6,638,000 | 4,296,000 | -2,489,000 | -4,600,000 | 9,027,000 | -1,659,000 | 2,780,000 | 2,402,000 | 3,026,000 | 4,948,000 | -3,615,000 | 327,000 | 7,806,000 |
contingent consideration | 0 | 0 | 0 | -467,000 | 14,000 | 0 | 0 | -4,524,000 | 0 | 0 | |||||||
other liabilities | 2,934,000 | -137,000 | -255,000 | -526,000 | -342,000 | -335,000 | -340,000 | -378,000 | -308,000 | -161,000 | -413,000 | -1,426,000 | 318,000 | -379,000 | -385,000 | 538,000 | -499,000 |
deferred revenue | 1,853,000 | -2,171,000 | -469,000 | -318,000 | 2,473,000 | -1,436,000 | -1,349,000 | 497,000 | 1,095,000 | -937,000 | -1,526,000 | 330,000 | -873,000 | 148,000 | -5,000 | -261,000 | 538,000 |
net cash from operating activities | 150,100,000 | 24,079,000 | -78,890,000 | -41,459,000 | 190,341,000 | -19,321,000 | -38,093,000 | 59,748,000 | 46,529,000 | -4,806,000 | -20,846,000 | 33,155,000 | -137,000 | -10,586,000 | -17,005,000 | -7,674,000 | 38,358,000 |
capex | -2,761,000 | -2,569,000 | -1,418,000 | -837,000 | -1,496,000 | -2,394,000 | -1,503,000 | -922,000 | -1,608,000 | -1,634,000 | -1,822,000 | -1,882,000 | -1,555,000 | -2,326,000 | -1,259,000 | -1,455,000 | -1,766,000 |
free cash flows | 147,339,000 | 21,510,000 | -80,308,000 | -42,296,000 | 188,845,000 | -21,715,000 | -39,596,000 | 58,826,000 | 44,921,000 | -6,440,000 | -22,668,000 | 31,273,000 | -1,692,000 | -12,912,000 | -18,264,000 | -9,129,000 | 36,592,000 |
cash flows from investing activities: | |||||||||||||||||
acquisitions of businesses, net of cash acquired | -5,086,000 | 0 | -319,835,000 | 208,000 | |||||||||||||
purchase of short-term and long-term investments | 603,000 | 450,000 | -15,252,000 | -33,298,000 | -102,138,000 | ||||||||||||
proceeds from the maturity and sale of short-term and long-term investments | 12,391,000 | 43,622,000 | 98,712,000 | 23,719,000 | |||||||||||||
capitalization of internally developed software | -2,421,000 | -2,082,000 | -1,310,000 | -736,000 | -1,277,000 | -2,045,000 | -1,259,000 | -856,000 | -1,336,000 | -1,444,000 | -1,368,000 | ||||||
purchases of property and equipment | -226,000 | -547,000 | -187,000 | -101,000 | -219,000 | -349,000 | -255,000 | -66,000 | -272,000 | -190,000 | -481,000 | -1,882,000 | -1,555,000 | -2,326,000 | -1,307,000 | -1,455,000 | -1,766,000 |
net cash from investing activities | 5,261,000 | 41,443,000 | -237,872,000 | -10,208,000 | -143,358,000 | -60,720,000 | -1,514,000 | -33,686,000 | -1,608,000 | -1,634,000 | -1,849,000 | -2,099,000 | -18,931,000 | -2,326,000 | -1,307,000 | -57,566,000 | -1,766,000 |
cash flows from financing activities: | |||||||||||||||||
proceeds from issuance of revolving credit facility | 0 | 0 | 125,000,000 | ||||||||||||||
payment of revolving credit facility | -45,000,000 | 0 | -65,000,000 | ||||||||||||||
payment of debt issuance costs | |||||||||||||||||
contingent consideration paid for acquisitions | -1,429,000 | 0 | -1,207,000 | 0 | 2,867,000 | 0 | -3,320,000 | 0 | 0 | ||||||||
payments of tax withholdings for net settled equity awards | -893,000 | ||||||||||||||||
common stock repurchased | -10,015,000 | -5,000,000 | -49,304,000 | -20,857,000 | |||||||||||||
proceeds from the issuance of stock under employee stock purchase plan | 1,285,000 | 0 | 1,242,000 | 0 | 1,693,000 | 0 | 1,415,000 | 0 | 1,827,000 | 0 | 864,000 | 0 | |||||
proceeds from exercise of stock options | 311,000 | 376,000 | 1,377,000 | 1,657,000 | 729,000 | 1,610,000 | 1,617,000 | 1,841,000 | 2,475,000 | 3,900,000 | 2,144,000 | 1,741,000 | 2,929,000 | 1,222,000 | 1,071,000 | 2,830,000 | 306,000 |
deferred acquisition payment | |||||||||||||||||
net cash from financing activities | -57,499,000 | -8,022,000 | 11,639,000 | -21,029,000 | -20,461,000 | 1,610,000 | 2,249,000 | -7,257,000 | 264,974,000 | 3,900,000 | 1,801,000 | -24,579,000 | 2,392,000 | 1,222,000 | -3,005,000 | 2,836,000 | -194,000 |
effect of exchange rates changes on cash and cash equivalents | 7,366,000 | 1,679,000 | 388,000 | 2,903,000 | -787,000 | -1,283,000 | 1,764,000 | -2,402,000 | 247,000 | 1,522,000 | -1,202,000 | 4,529,000 | 1,702,000 | -1,366,000 | -294,000 | ||
net decrease in cash and cash equivalents | 105,228,000 | 59,179,000 | -304,735,000 | ||||||||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 495,242,000 | 0 | |||||||||||||
cash and cash equivalents, end of period | 105,228,000 | 59,179,000 | 190,507,000 | 25,735,000 | |||||||||||||
supplemental disclosures of cash flow and noncash information | |||||||||||||||||
purchase of property and equipment in accounts payable | -114,000 | 60,000 | 79,000 | 11,000 | 27,000 | 48,000 | |||||||||||
issuance of common stock upon settlement of restricted stock units | 19,883,000 | 15,072,000 | |||||||||||||||
issuance of common stock for retention bonus | 324,000 | 700,000 | |||||||||||||||
accrued excise tax related to common stock repurchased | 31,000 | -191,000 | 479,000 | ||||||||||||||
deferred tax provision | -171,000 | 1,174,000 | -1,181,000 | -426,000 | -48,000 | -53,000 | 19,000 | -10,000 | |||||||||
other | 61,000 | ||||||||||||||||
benefit from uncollectible accounts | 28,000 | 41,000 | -3,000 | -105,000 | -16,000 | -199,000 | -74,000 | 516,000 | 83,000 | ||||||||
non-cash interest expense | 46,000 | 46,000 | 46,000 | 46,000 | 92,000 | 56,000 | 98,000 | 72,000 | 72,000 | 80,000 | 110,000 | 77,000 | 81,000 | 81,000 | 71,000 | ||
non-cash interest income | -508,000 | ||||||||||||||||
payment of long-term debt issuance costs | 0 | 0 | 0 | -783,000 | 0 | ||||||||||||
payments of tax withholdings for net settled option exercises | -1,676,000 | 0 | -1,808,000 | 0 | -756,000 | ||||||||||||
proceeds from issuance of common stock under public offering, net of underwriting discount and commissions | |||||||||||||||||
payments of costs related to public offering | -615,000 | ||||||||||||||||
repayment of long-term debt | 0 | ||||||||||||||||
net increase in cash, cash equivalents and restricted cash | 16,403,000 | -53,000 | -11,354,000 | -7,161,000 | -19,615,000 | -63,770,000 | 36,104,000 | ||||||||||
cash, cash equivalents and restricted cash, beginning of year | |||||||||||||||||
cash, cash equivalents and restricted cash, end of year | |||||||||||||||||
accretion of discounts on investments, net of amortization of premiums | -908,000 | ||||||||||||||||
proceeds from issuance of common stock under public offering, net of underwriter discounts and commissions | |||||||||||||||||
net increase in cash and cash equivalents | |||||||||||||||||
proceeds from sale of long-term investments | |||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -35,594,000 | -1,018,000 | -22,096,000 | ||||||||||||||
cash, cash equivalents and restricted cash, beginning of period | 654,608,000 | 0 | 0 | 351,177,000 | 0 | 0 | 389,360,000 | 0 | |||||||||
cash, cash equivalents and restricted cash, end of period | 619,014,000 | 310,142,000 | -1,018,000 | 329,081,000 | -11,354,000 | -7,161,000 | 369,745,000 | 36,104,000 | |||||||||
reconciliation of cash, cash equivalents and restricted cash | |||||||||||||||||
cash and cash equivalents | 619,014,000 | 327,081,000 | 365,745,000 | ||||||||||||||
restricted cash | 2,000,000 | 4,000,000 | |||||||||||||||
cash, cash equivalents and restricted cash | 619,014,000 | 329,081,000 | 369,745,000 | ||||||||||||||
amortization of contract costs | |||||||||||||||||
change in fair value of preferred stock warrant liability | 0 | 0 | |||||||||||||||
asset acquisition, net of cash acquired | 0 | 0 | |||||||||||||||
proceeds from initial public offering, net of underwriting discount and commissions | |||||||||||||||||
payment of costs related to initial public offering | 0 | -1,015,000 | |||||||||||||||
proceeds from issuance of long-term debt | 6,000 | ||||||||||||||||
proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | 0 | 0 | |||||||||||||||
proceeds from exercise of warrants | 0 | 0 | |||||||||||||||
business acquisition, net of cash acquired | |||||||||||||||||
payments of tax withholdings for net settled stock option exercises | |||||||||||||||||
cash paid during the period for interest | 95,000 | ||||||||||||||||
payment of deferred offering costs related to initial public offering | |||||||||||||||||
bad debt expense | 13,000 | 53,000 | 20,000 | 75,000 | 10,000 | ||||||||||||
acquisition of businesses, net of cash acquired | |||||||||||||||||
proceeds from initial public offering, net of underwriting discounts and commissions | 0 | ||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | |||||||||||||||||
changes in operating assets and liabilities, net of acquisition: | |||||||||||||||||
prepaid expenses and other current assets | 262,000 | ||||||||||||||||
accretion of redeemable convertible preferred stock | |||||||||||||||||
deferred offering costs related to initial public offering included in accounts payable, accrued expenses and other current liabilities | |||||||||||||||||
repurchase of common stock | |||||||||||||||||
deferred consideration paid for acquisitions | |||||||||||||||||
prepaid expenses and other assets | 407,000 | ||||||||||||||||
payment of long-term debt |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
